AUPH Q4 2018 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29,000-6.5% YoY

Gross Profit

-$11M-37275.9% margin

Operating Income

-$15M-50562.1% margin

Net Income

-$15M-50320.7% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

-92.3%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$146M

Total Liabilities

$33M

Stockholders' Equity

$113M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29,000	$31,000	-6.5%
Gross Profit	-$11M	-$9M	-24.8%
Operating Income	-$15M	-$12M	-20.8%
Net Income	-$15M	-$3M	-338.0%